About
AAV Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide Therapy
Team (8)
Bruce Goldsmith, Ph.D.
Investor Relations
Axovia Therapeutics
team_member
Charmaine O’Neill
Vice President Clinical Operations
Axovia Therapeutics
executive
Elizabeth Forsythe
Medical Director (Consultant)
Axovia Therapeutics
team_member
Jo Broadhead, Ph.D.
CMC Lead (Consultant)
Axovia Therapeutics
team_member
Lorna Collings
Chief Financial Officer
Axovia Therapeutics
executive
Narges Amini, Ph.D.
Programme Director
Axovia Therapeutics
team_member
Locations (1)
Headquarters
London, UK
Map
Loading map...